Use of DTBZ to image pancreatic endocrine and beta cell populations in type 1 diabetes

摘要

This invention in the pancreas of the non invasive object, being the method of deciding the cell population, the process which prescribes the vesicular mono amine trance porter 2 type (VMAT2) - unique radioactive ligand of the effective quantity to the aforementioned object; Concerning at least the portion of the pancreas of the aforementioned object, the process which at least acquires the computer conversion picture of 1; And, in the pancreas of the aforementioned object, in order that the cell population is decided, including the process which it measures analyzes the aforementioned computer conversion picture, it offers the method of becoming. In addition, as for this invention, the method of diagnosing nervous incretion obstacle such as insurinoma, diabetes, and the front clinical diabetes in the metabolism object, and the method of deciding the disposal efficiency of metabolism obstacle are offered. Furthermore, this invention diabetes offers the method of managing the disposal or prevention of method, and the diabetes which appraise the convalescence of the object which has the fear of emerging. In addition, this invention in the pancreas of the object, the kit which is used for the diagnosis of metabolism obstacle or nervous incretion obstacle of decision, and the object of the cell population is offered. Selective figure It is not